NEW ORLEANS, LA—Ever since statin guidelines were revised to urge physicians to prescribe high-intensity statins rather than treating to a specific LDL target, the debate has continued: is the “fire ...
How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to ...
New research suggests physicians face a Herculean task to get Americans with atherosclerotic cardiovascular disease (ASCVD) to take high-intensity statins, despite multiple professional guidelines ...
Email reminders to physicians about proper dosing of high-intensity statins, individualized to specific patients and often timed around their appointments, significantly improved the likelihood of ...
Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...
Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were significantly more likely to be prescribed guideline-recommended high-intensity statin therapy ...
Please provide your email address to receive an email when new articles are posted on . Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases ...
In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
The path to atherosclerotic cardiovascular disease (ASCVD) often starts in youth, as significantly abnormal lipid levels typically track into adulthood and lay the groundwork for clinical events in ...
Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...
Data showed differences in statin use to prevent cardiovascular disease among Finnish patients with type 2 diabetes. Results of a retrospective cohort study revealed many patients with type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback